Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The ADEM2 project: early pathogenic mechanisms of preschool wheeze and a randomised controlled trial assessing the gain in health and cost-effectiveness by application of the breath test for the diagnosis of asthma in wheezing preschool children. | BMC Public Health | 2023 | 37013496 | PubTator, text mining | PubMed |
| Editorial: Host-microbiota and cancer. | Front Oncol | 2023 | 37007088 | PubTator, text mining | PubMed |
| Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma. | Cancer Sci | 2023 | 37002866 | PubTator, text mining | PubMed |
| Single cell RNA-seq resolution revealed CCR1+/SELL+/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37001702 | PubTator, text mining | PubMed |
| A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery. | Front Immunol | 2023 | 36993954 | PubTator, text mining | PubMed |
| A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections. | Front Genet | 2023 | 36992700 | PubTator, text mining | PubMed |
| Expression of Gal-9 on Dendritic Cells and Soluble Forms of TIM-3/Gal-9 in Patients Suffering from Endometriosis. | Int J Mol Sci | 2023 | 36983021 | PubTator, text mining | PubMed |
| Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer? | Int J Mol Sci | 2023 | 36982898 | PubTator, text mining | PubMed |
| Molecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System. | Int J Mol Sci | 2023 | 36982782 | PubTator, text mining | PubMed |
| Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer. | Int J Mol Sci | 2023 | 36982677 | PubTator, text mining | PubMed |
| The Role of Toll-like Receptor 2 (TLR2) in the Development and Progression of Hashimoto's Disease (HD): A Case Study on Female Patients in Poland. | Int J Mol Sci | 2023 | 36982416 | PubTator, text mining | PubMed |
| Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens. | Int J Mol Sci | 2023 | 36982316 | PubTator, text mining | PubMed |
| Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma. | Biomolecules | 2023 | 36979473 | PubTator, text mining | PubMed |
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. | Clin Transl Med | 2023 | 36967539 | PubTator, text mining | PubMed |
| Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases. | Cancer Med | 2023 | 36965095 | PubTator, text mining | PubMed |
| Dendritic cell subsets in cancer immunity and tumor antigen sensing. | Cell Mol Immunol | 2023 | 36949244 | PubTator, text mining | PubMed |
| Analysis and purification of innate lymphoid cells in human intestine and blood by flow cytometry. | STAR Protoc | 2023 | 36943862 | PubTator, text mining | PubMed |
| Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata. | Elife | 2023 | 36930216 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. | Cancer Discov | 2023 | 36929873 | PubTator, text mining | PubMed |
| Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC. | JTO Clin Res Rep | 2023 | 36925644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=13